A group of researchers from the University of Cincinnati has discovered a possible novel approach to enhance the efficacy of radiation therapy and enhance the prognosis of patients with lung cancer metastasizing to the brain.
According to a recent study, medications intended to treat blood and other malignancies may also increase the effectiveness of radiation therapy for low-grade brain tumours in adults.
Damage to nerves brought on by cancer therapies frequently results in symptoms that endure a lifetime. In some circumstances, medication has not worked. Simple exercises can prevent nerve injury, according to research.
Researchers discovered a protein CDK7 that could prevent heart damage caused by a routinely used cancer chemotherapy treatment. Importantly, the researchers discovered that blocking CDK7 could improve the medication's cancer-killing efficacy.
Certain anti-cancer medications also target healthy cells in addition to malignant cells. Their use may become restricted if their effects on the latter are excessively powerful. The mechanism of action of PARP inhibitors, which are specifically used for treating breast and ovarian cancer in
Cancerous tumours consist of a mixture of cells, the most important of which are cancer stem cells. These cells are capable of establishing new cancerous tumours by evading the immune response.
A group led by scientists at The University of Texas at Austin has discovered a brand-new, bio-inspired medication that restores the capability of immune cells to combat cancer. The medication increases the effectiveness of immunotherapy and inhibits tumour growth in mice models of melanoma,
A recent study from the University of Michigan Department of Neurosurgery and Rogel Cancer Centre demonstrates encouraging preliminary findings that a therapy combining cell-killing and immune-stimulating drugs is safe and effective in extending survival for patients with gliomas, a particu
Treatment for over 80 per cent of breast cancer survivors does not end with surgery, radiation, and chemotherapy. Instead, doctors advise them to take medication to inhibit sex hormones, which can fuel tumour growth and cause recurrence, for the next five to ten years.
Women with breast cancer will be enrolled in a clinical trial to investigate the ability of behavioural and psychological therapy to minimise the cardiac damage caused by anti-cancer medications. The unique CARDIOCARE initiative is being led by a coalition of European partners, including the